Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.87%210.2B | 0.94%840.4B | 4.07%216.42B | 9.04%832.54B | 11.43%219.84B | 1.03%192.53B | 7.32%212.21B | 16.89%207.95B | 27.13%763.52B | 25.18%197.3B |
| Cost of revenue | -5.35%162.89B | 3.09%672.23B | 8.52%172.09B | 10.20%652.06B | 18.86%179.69B | 2.58%149.73B | 3.72%164.06B | 16.27%158.58B | 27.21%591.71B | 23.29%151.18B |
| Gross profit | 6.73%47.31B | -6.82%168.17B | -10.22%44.33B | 5.04%180.48B | -12.94%40.15B | -4.06%42.8B | 21.70%48.15B | 18.93%49.38B | 26.87%171.82B | 31.83%46.12B |
| Operating expense | 2.21%40.44B | 4.88%151.68B | 13.70%39.57B | 5.56%144.62B | 2.60%36.38B | 5.28%36.74B | 9.90%36.7B | 4.66%34.8B | 18.67%137B | 20.09%35.46B |
| Selling and administrative expenses | -51.61%18.61B | 4.26%147.6B | 11.76%38.46B | 6.96%141.57B | 4.73%35.51B | 6.24%35.67B | 9.77%35.97B | 7.21%34.42B | 17.52%132.36B | 17.07%33.91B |
| -Selling and marketing expense | 7.47%18.61B | 5.09%67.39B | 9.12%17.32B | 0.17%64.12B | 3.51%16.33B | -0.49%15.71B | -1.58%16.21B | -0.66%15.87B | 20.57%64.01B | 12.83%15.78B |
| -General and administrative expense | ---- | 3.57%80.21B | 14.01%21.15B | 13.32%77.45B | 5.78%19.18B | 12.22%19.96B | 21.23%19.76B | 15.01%18.55B | 14.81%68.35B | 21.03%18.13B |
| Other operating expenses | 1,649.81%22.94B | 47.76%6.59B | 107.77%1.31B | -29.32%4.46B | 2.68%1.76B | -22.88%1.22B | -45.48%850M | -56.72%631M | 25.21%6.31B | 23.95%1.72B |
| Total other operating income | 440.98%1.11B | 78.21%2.51B | -17.00%205M | -15.32%1.41B | 438.55%894M | -41.31%152M | -87.55%116M | -19.54%247M | -24.84%1.66B | -79.81%166M |
| Operating profit | 44.27%6.87B | -54.01%16.49B | -67.33%4.76B | 3.01%35.86B | -64.65%3.77B | -37.59%6.07B | 85.52%11.45B | 76.38%14.58B | 74.23%34.81B | 95.33%10.66B |
| Net non-operating interest income (expenses) | -13.25%-6.78B | 10.33%-25.29B | 6.25%-5.98B | -62.10%-28.21B | -28.33%-7.81B | -33.66%-6.35B | -104.84%-7.66B | -126.27%-6.38B | -39.56%-17.4B | -76.75%-6.09B |
| Non-operating interest income | -5.02%1.25B | -67.59%3.44B | -48.41%1.32B | 102.52%10.61B | 276.03%4.36B | 69.21%1.97B | 8.62%1.73B | 92.52%2.55B | 147.47%5.24B | 66.19%1.16B |
| Non-operating interest expense | 9.96%8.03B | -25.98%28.73B | -18.28%7.3B | 71.45%38.82B | 67.97%12.18B | 40.66%8.33B | 76.14%9.38B | 115.49%8.93B | 55.22%22.64B | 74.97%7.25B |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -10.39%975M | -9.63%5.53B | -48.24%1.09B | 5.23%6.12B | -7.73%1.41B | -20.96%1.39B | -18.39%1.22B | 102.50%2.1B | 42.57%5.81B | 200.99%1.53B |
| Special income (charges) | 842.37%1.67B | -237.05%-5.25B | -94.05%177M | 108.48%3.83B | 31.15%-840M | -36.85%641M | 102.23%1.05B | 27.45%2.98B | -16,700.74%-45.15B | 70.10%-1.22B |
| Less:Other special charges | -842.37%-1.67B | 5,932.22%5.25B | -123.17%-177M | -100.20%-90M | -31.15%840M | 36.85%-641M | -102.23%-1.05B | 132.72%764M | 1,338.45%45.15B | 72.80%1.22B |
| Less:Write off | ---- | --0 | --0 | ---3.74B | --0 | ---- | ---- | ---3.74B | --0 | --0 |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 6,262.79%2.74B | -148.45%-8.53B | -99.68%43M | 180.23%17.6B | -171.34%-3.48B | -77.50%1.74B | 113.98%6.06B | 50.54%13.27B | -284.95%-21.93B | 236.14%4.88B |
| Income tax | 187.29%2.28B | -25.89%4.94B | -145.60%-2.61B | -26.61%6.67B | -129.73%-322M | -133.37%-1.85B | 201.47%3.11B | 3.71%5.73B | 78.12%9.08B | 495.05%1.08B |
| Net income | -82.87%455M | -223.20%-13.47B | -64.79%2.66B | 135.24%10.93B | -183.23%-3.16B | 63.31%3.59B | 107.33%2.96B | 129.13%7.54B | -558.90%-31.02B | 200.77%3.79B |
| Net income continuous operations | -82.87%455M | -223.20%-13.47B | -64.79%2.66B | 135.24%10.93B | -183.23%-3.16B | 63.31%3.59B | 107.33%2.96B | 129.13%7.54B | -558.90%-31.02B | 200.77%3.79B |
| Noncontrolling interests | 137.89%609M | 22.90%365M | -50.39%256M | -89.18%297M | -172.77%-286M | -126.62%-144M | -76.56%211M | -43.30%516M | 4.53%2.74B | -46.60%393M |
| Net income attributable to the company | -106.42%-154M | -230.08%-13.83B | -65.85%2.4B | 131.49%10.63B | -184.44%-2.87B | 125.36%3.73B | 106.66%2.74B | 195.00%7.03B | -916.67%-33.76B | 175.55%3.4B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -106.42%-154M | -230.08%-13.83B | -65.85%2.4B | 131.49%10.63B | -184.44%-2.87B | 125.36%3.73B | 106.66%2.74B | 195.00%7.03B | -916.67%-33.76B | 175.55%3.4B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -133.41%-7.02 | -281.55%-173.2 | -70.80%21.01 | 124.27%95.4 | -214.71%-36.89 | 177.91%35.6 | 105.40%24.77 | 244.59%71.95 | -1,732.99%-393.06 | 158.57%32.16 |
| Diluted earnings per share | -141.56%-7.02 | -331.40%-173.2 | -65.82%16.89 | 119.04%74.85 | -214.71%-36.89 | 125.41%26.26 | 104.21%19.31 | 194.69%49.42 | -1,743.23%-393.06 | 158.57%32.16 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |